Minimal Clinically Significant Difference (MCID) of Multidimensional Dyspnea Profile (MDP) in COPD Patients Undergoing Respiratory Rehabilitation
NCT ID: NCT06012006
Last Updated: 2024-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
120 participants
INTERVENTIONAL
2024-09-30
2025-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Time of Exercise Re-training With Chronic Obstructive Pulmonary Disease (COPD)
NCT06366113
Respiratory Rehabilitation for Patients With Chronic Obstructive Pulmonary Disease
NCT03453606
Home Pulmonary Rehabilitation for COPD
NCT03480386
Effect and Feasibility of Non-linear Periodized Resistance Training in People With COPD
NCT03518723
Pulmonary Rehab, Dyspnea, Walk and Step Testing in COPD
NCT02542826
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* The A1 score will be compared with the Borg Affective Dyspnea (BorgA) scale.
* The sensory score will be compared with the Borg Sensory Dyspnea Scale (BorgS).
* The 5 sensory items will be compared with the Borg Sensory Dyspnea scale.
* The emotional score will be compared with the Borg Emotional Dyspnea Scale.
* The 5 emotional items will be compared with the Borg affective dyspnea scale. The various questionnaires will be administered to patients at inclusion, after a constant work-rate cycling exercise test, and at isotime during the same cycling exercise test at the end of the pulmonary rehabilitation course.
The sensitivity study will be conducted using the visual analog dyspnea scale instead of the Borg score. Finally, we will also determine the MCID using the distribution method. The MCID score will be correlated with various quality of life and physical performance scores.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pulmonary rehabilitation
COPD patients will be admitted for pulmonary rehabilitation, the duration and modalities of which vary from center to center.
constant work-rate cycling exercise test
Description: at the end of pulmonary rehabilitation, a constant work-rate second cycling exercise test will be performed with the same duration as the cycling exercise test at inclusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
constant work-rate cycling exercise test
Description: at the end of pulmonary rehabilitation, a constant work-rate second cycling exercise test will be performed with the same duration as the cycling exercise test at inclusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Moderate to severe obstructive ventilatory disorder (FEV1\<80%)
* Admitted for a pulmonary rehabilitation
* Having given free, informed and written consent
Exclusion Criteria
* Cognitive impairment preventing completion of questionnaires
* Patient under guardianship
* Patient not affiliated to the social security system
* Chronic ethylism
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Capucine Morelot-Panzini, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
APHP
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APHP221339
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.